-+ 0.00%
-+ 0.00%
-+ 0.00%

Janux Therapeutics announces annual shareholder meeting notice

PUBT·04/28/2026 20:29:41
Listen to the news
Janux Therapeutics announces annual shareholder meeting notice
  • Janux Therapeutics will hold 2026 annual stockholder meeting virtually over internet on June 11, 2026.
  • Shareholders will vote on election of two Class II directors, including nominees Natasha Hernday and Eric Dobmeier.
  • Meeting agenda also includes ratification of Ernst & Young as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.
  • Advisory vote will be held on compensation of named executive officers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Janux Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-187095), on April 28, 2026, and is solely responsible for the information contained therein.